TMO(TMO)
TMO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $47.84B | $50.31B | $53.49B | $57.02B | $58.77B |
| Low | $47.54B | $49.96B | $52.63B | $56.50B | $58.24B |
| High | $48.08B | $50.98B | $54.80B | $57.74B | $59.51B |
| EBITDA Avg | $13.06B | $13.73B | $14.60B | $15.57B | $16.04B |
| Low | $12.98B | $13.64B | $14.37B | $15.42B | $15.90B |
| High | $13.13B | $13.92B | $14.96B | $15.76B | $16.24B |
| EBIT Avg | $9.66B | $10.15B | $10.79B | $11.51B | $11.86B |
| Low | $9.60B | $10.08B | $10.62B | $11.40B | $11.75B |
| High | $9.70B | $10.29B | $11.06B | $11.65B | $12.01B |
| Net Income Avg | $9.45B | $10.12B | $11.01B | $12.90B | $14.73B |
| Low | $9.42B | $9.95B | $10.22B | $12.75B | $14.56B |
| High | $9.49B | $10.92B | $12.41B | $13.11B | $14.97B |
| EPS Avg | $25.08 | $27.40 | $30.21 | $34.21 | $39.07 |
| Low | $24.97 | $26.39 | $27.12 | $33.81 | $38.61 |
| High | $25.17 | $28.96 | $32.91 | $34.77 | $39.71 |
| Analysts (Rev / EPS) | 20 / 14 | 20 / 16 | 17 / 5 | 13 / 1 | 8 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $11.95B | $12.93B | $11.74B | $12.42B | $12.50B | $13.55B | $12.49B | $13.19B |
| Low | $11.74B | $12.85B | $11.60B | $12.27B | $12.35B | $13.38B | $12.34B | $13.03B |
| High | $12.06B | $13.04B | $11.87B | $12.56B | $12.64B | $13.69B | $12.63B | $13.34B |
| EBITDA Avg | $3.26B | $3.53B | $3.21B | $3.39B | $3.41B | $3.70B | $3.41B | $3.60B |
| Low | $3.20B | $3.51B | $3.17B | $3.35B | $3.37B | $3.65B | $3.37B | $3.56B |
| High | $3.29B | $3.56B | $3.24B | $3.43B | $3.45B | $3.74B | $3.45B | $3.64B |
| EBIT Avg | $2.41B | $2.61B | $2.37B | $2.51B | $2.52B | $2.73B | $2.52B | $2.66B |
| Low | $2.37B | $2.59B | $2.34B | $2.48B | $2.49B | $2.70B | $2.49B | $2.63B |
| High | $2.43B | $2.63B | $2.40B | $2.54B | $2.55B | $2.76B | $2.55B | $2.69B |
| Net Income Avg | $2.37B | $2.70B | $2.22B | $2.44B | $2.57B | $2.93B | $2.52B | $2.68B |
| Low | $2.36B | $2.68B | $2.19B | $2.40B | $2.53B | $2.88B | $2.48B | $2.64B |
| High | $2.40B | $2.73B | $2.26B | $2.47B | $2.60B | $2.97B | $2.56B | $2.72B |
| EPS Avg | $6.40 | $7.28 | $5.99 | $6.56 | $6.92 | $7.89 | $6.79 | $7.24 |
| Low | $6.37 | $7.23 | $5.90 | $6.46 | $6.81 | $7.76 | $6.68 | $7.12 |
| High | $6.47 | $7.37 | $6.08 | $6.66 | $7.02 | $8.00 | $6.89 | $7.34 |
| Analysts (Rev / EPS) | 13 / 15 | 13 / 14 | 11 / 6 | 12 / 11 | 6 / 6 | 6 / 9 | 5 / 10 | 5 / 7 |